Acute coronary syndrome (ACS) is a rare fatal consequence in a patient of intracranial haemorrhage (ICH). The complexity in devising a management strategy in such scenario is a considerable challenge to the clinician. The dire need for anticoagulation in the peri-procedural period once percutaneous coronary intervention (PCI) is planned to treat ACS is an absolute contraindication in a case of ICH. We present a plausible management strategy in such scenario thorough this case report of a 43 year old gentleman who presented with ICH and ACS. The beneficial role of cangrelor as a potential bridge for PCI in ACS complicating a case of ICH is highlighted.